Views & Analysis Why should pharma invest in digital products for those livin... Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges.
News Data privacy concerns don't hinder digital health app usage A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on
Views & Analysis Managing chronic illness in children and adolescents With up to a quarter of US children and adolescents affected by a chronic condition, Sinead Ni Mhurchadha and Anna O’Sullivan stress the importance of understanding their needs and developing t
Views & Analysis Patient-centricity and long-term conditions – where next? Comprehensive guidance, education and training are vital to upskill clinicians and others in patient-centred healthcare.
Views & Analysis Addressing the challenges of chronic disease Technology will play a big part in management of people with long-term conditions.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.